Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis
Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Jun 18, 2018
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective home-based pulmonary rehabilitation (PR) is compared to hospital-based PR for patients with bronchiectasis, a lung condition that makes it hard to breathe. The goal is to find out which method helps patients improve their lung function and overall health better. The trial is currently looking for participants aged 18 to 70 who have been diagnosed with bronchiectasis and are stable, meaning their condition is not worsening.
If you or a family member are considering participation, you should know that you need to be able to sign a consent form and meet certain health criteria. For example, those with severe heart issues or other medical conditions that could hinder exercise won't be eligible. Participants can expect to engage in rehabilitation activities either at home or in a hospital setting, depending on the group they are assigned to. This research will help doctors understand the best ways to support patients with bronchiectasis in managing their condition effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 18-70
- • Patients signing informed consent form
- • Bronchiectasis patients in the stable phase who were diagnosed with High-resolution computed tomography (HRCT).
- Exclusion Criteria:
- • Decompensated heart failure, uncontrolled hypertension (Systolic Blood Pressure\> 200, Diastolic Blood Pressure\> 110),
- • Additional diseases that may prevent exercise,
- • To be regularly exercising regularly
About Istanbul Medipol University Hospital
Istanbul Medipol University Hospital is a leading healthcare institution in Turkey, renowned for its commitment to advanced medical research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate innovative studies across various medical fields. With a strong emphasis on patient safety and ethical standards, Istanbul Medipol University Hospital strives to contribute to the advancement of medical knowledge and the development of effective treatments, ensuring high-quality care and improved health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Zeytinburnu, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials